1.RECONSTRUCTION OF THE SOFT TISSUE DEFECT OF PELVIS AND GROIN AREA USING RECTUS ABDOMINIS AND GRACILIS MUSCLE FLAP.
Jae Hwa LEE ; Hoon Bum LEE ; Sug Won KIM ; Joo Bong KIM ; Dae Hyun LEW ; Yoon Kyu CHUNG ; Sung Kwan HWANG
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1997;24(6):1439-1446
No abstract available.
Groin*
;
Pelvis*
;
Rectus Abdominis*
2.BP Values Difference Depending on the Height of Hand Position in Oscillometric Electronic Digital BP Monitor and Its Comparison with Mercury Sphygmomanometer.
Jae Min KIM ; Ju Won KWON ; Joung Min SUN ; Ja Yo JEONG ; Bong Hwa KIM ; Du Yong LEE ; Sug Joo YOON ; Chong Suhl KIM ; Young Sook KIM
Korean Circulation Journal 1992;22(6):1017-1023
BACKGROUND: There is pressure difference depending on the height of hand position when blood pressure is taken, applying the oscillometric electronic digital BP(blood pressure) monitor. Authors have calculated the degree of BP differences, and evaluated the accuracy and effectiveness of the digital BP monitor comparing with the conventional Mercury Sphygmomanometer. METHOD: Randomized sixty cases consisting of in-patients and hospital workers were subjected for this study. BPs were taken at three different levels-nose level, heart level and knee level-on conventional sitting position applying OMRON Digital Automatic Blood Pressure Monitor and conventional Mercury Sphygmomanometer, and statistical analysis was made. RESULTS: At the nose level, systolic BP and diastolic BP were lower with 23.5mmHg and 18.9mmHg respectively, than at the heart level, while at the knee level, they were higher with 21mmHg and 17.5mmHg respectively, than at the heart level. No actual statistical difference of systolic and diastolic values between OMRON Digital Automatic Blood Pressure Monitoring method at the heart level and conventional Mercury Sphygmomanometeric method. CONCLUSION: Present study demonstrated significant discrepancy of BP values, in systolic and diastolic values, depending on the height of measured finger, when OMRON Digital Automatic Blood Pressure Monitor is applied in taking BP on conventional sitting position. However, no actual discrepancy of BP values was noted between two methods when BP is taken at heart level by OMRON Digital Automatic Blood Pressure Monitor and on brachial artery BP by conventional Mercury Sphygmomanometer. Thus OMRON Digital Automatic Blood Pressure Monitor could take the place of Mercury Sphygmomanometer in taking peripheral BP, which subsequently enable us to estimate central artery BP, which is believed to be better clinical index, through this much more handy electrical oscillometric device in the future.
Arteries
;
Blood Pressure
;
Blood Pressure Monitors
;
Brachial Artery
;
Electric Impedance
;
Fingers
;
Hand*
;
Heart
;
Hydrostatic Pressure
;
Knee
;
Nose
;
Sphygmomanometers*
3.Rapid increase of cytosolic content of acetyl-CoA carboxylase isoforms in H9c2 cells by short-term treatment with insulin and okadaic acid.
Chang Eun PARK ; Sun Min KO ; Jung Mok KIM ; Moon Young YOON ; Ja Young KIM ; In Sug KANG ; Sung Soo KIM ; Joo Hun HA
Experimental & Molecular Medicine 1998;30(2):73-79
Mammalian acetyl-CoA carboxylase (ACC) is present in two isoforms, alpha and beta, both of which catalyze formation of malonyl-CoA by fixing CO2 into acetyl-CoA. ACC-alpha is highly expressed in lipogenic tissues whereas ACC-beta is a predominant form in heart and skeletal muscle tissues. Even though the tissue-specific expression pattern of two ACC isoforms suggests that each form may have a distinct function, existence of two isoforms catalyzing the identical reaction in a same cell has been a puzzling question. As a first step to answer this question and to identify the possible role of ACC isoforms in myogenic differentiation, we have investigated in the present study whether the expression and the subcellular distribution of ACC isoforms in H9c2 cardiac myocyte change so that malonyl-CoA produced by each form may modulate fatty acid oxidation. We have observed that the expression levels of both ACC forms were correlated to the extent of myogenic differentiation and that they were present not only in cytoplasm but also in other subcellular compartment. Among the various tested compounds, short-term treatment of H9c2 myotubes with insulin or okadaic acid rapidly increased the cytosolic content of both ACC isoforms up to 2 folds without affecting the total cellular ACC content. Taken together, these observations suggest that both ACC isoforms may play a pivotal role in muscle differentiation and that they may translocate between cytoplasm and other subcellular compartment to achieve its specific goal under the various physiological conditions.
Acetyl-CoA Carboxylase/metabolism*
;
Acetyl-CoA Carboxylase/drug effects
;
Animal
;
Cell Differentiation/drug effects
;
Cell Line
;
Cell Membrane Permeability
;
Chromones/pharmacology
;
Cytosol/enzymology*
;
Cytosol/drug effects
;
Digitonin/pharmacology
;
Immunoblotting
;
Insulin/pharmacology*
;
Isoenzymes
;
Morpholines/pharmacology
;
Myocardium/cytology
;
Okadaic Acid/pharmacology*
;
Phosphorylation
;
Rats
4.The value of concurrent chemoradiotherapy in the treatment of loco-regionally advanced cervical cancer.
Young Han PARK ; Hee Sug RYU ; Ki Hong CHANG ; Mi Son CHUN ; Jong Hyuck YOON ; Jong Man RYOU ; Jung Pil LEE ; Eun Joo LEE
Korean Journal of Obstetrics and Gynecology 2002;45(4):633-641
OBJECTIVE: The purpose of this study was to evaluate the efficacy and toxicity of concurrent chemor- adiotherapy (CCRT) in loco-regionally advanced cervical cancer patients. METHODS: The medical records of 24 patients were retrospectively reviewed who underwent CCRT' and 62 patients who had underwent radiation therapy alone at the Department of Obstetrics and Gynecology, Ajou University Hospital from September, 1994 to August 2000 for loco-regionally advanced cervical cancer (stage IIb-IVa and Ib-IIa with bulky tumor mass or pelvic lymph node involvement detected by magnetic resonance imaging). Radiotherapy was performed for 7 weeks during which the patients underwent radiotherapy and chemotherapy concomitantly. Chemotherapeutic regimen consisted of cisplatin (75 mg/m2 on day 1, 4) and 5-FU (1000 mg/m2 on day 2-5, 30-33). The toxicity was assessed according to the GOG toxicity criteria. RESULTS: In the CCRT group, 2 of 18 patients (11.1%) had recurrent disease. Of the 22 patients who were followed up, the overall survival rate was 83.3%, and the relapse-free survival rate was 89.9%. In the radiotherapy alone group, 19 of 61 patients (32.3%) had recurrent disease. Of the 62 patients who were followed up, the overall survival rate was 75.4% and the relapsed-free survival rate was 67.7%. Relative risk reduction rate of the death rate in the CCRT group was 66% (RR 0.34), and 32% (RR 0.68) in the recurrence rate. Acute toxicities in the CCRT group were enteritis grade 3:3 (12.5%), leukopenia grade 3:2 (8.3%), anemia grade 3:1 (4.1%) and grade 4:2 (8.3%). The acute toxicities in the radiation therapy alone group were enteritis grade 3:7 (11.3%), rectal bleeding grade 3:1 (1%). Increased acute toxicities developed in the CCRT group. CONCLUSION: This study shows improved overall survival rates and relapse-free survival rates but some increase in acute toxicity. It is suggested that CCRT be the standard treatment of loco-regionally advanced cervical cancer. Due to small size sample and short duration of follow up, further study of a large group of patients and the long term survival rate are necessary.
Anemia
;
Chemoradiotherapy*
;
Cisplatin
;
Drug Therapy
;
Enteritis
;
Fluorouracil
;
Follow-Up Studies
;
Gynecology
;
Hemorrhage
;
Humans
;
Leukopenia
;
Lymph Nodes
;
Medical Records
;
Mortality
;
Obstetrics
;
Radiotherapy
;
Recurrence
;
Retrospective Studies
;
Risk Reduction Behavior
;
Survival Rate
;
Uterine Cervical Neoplasms*
5.Clinicopathologic characteristics of ovarian clear cell carcinoma in the background of endometrioma: a surveillance strategy for an early detection of malignant transformation in patients with asymptomatic endometrioma.
Joo Hyuk SON ; Seokyoung YOON ; Seokyung KIM ; Tae Wook KONG ; Jiheum PAEK ; Suk Joon CHANG ; Hee Sug RYU
Obstetrics & Gynecology Science 2019;62(1):27-34
OBJECTIVE: This study aimed to analyze the clinical features of clear cell carcinoma in relation to endometriosis and to determine an appropriate surveillance strategy for the early detection of malignant transformation of endometrioma in asymptomatic patients. METHODS: We retrospectively reviewed the clinicopathologic data of 50 patients with ovarian clear cell carcinoma. Clinicopathologic characteristics, treatment outcomes, and the association between endometriosis and the risk of malignant transformation were analyzed. RESULTS: Ten (20%) patients had been diagnosed with endometrioma before the diagnosis of clear cell carcinoma. The median period from the diagnosis of endometrioma to clear cell carcinoma diagnosis was 50 months (range, 12–213 months). After complete staging surgery, histological confirmation of endometriosis was possible in 35 (70%) patients. Of the 50 patients, 39 (78%) had not undergone any gynecologic surveillance until the onset of symptoms, at which time many of them presented with a rapidly growing pelvic mass (median 10 cm, range 4.6–25 cm). With the exception of 2 patients, all cancer diagnoses were made when the patients were in their late thirties, and median tumor size was found to increase along with age. Asymptomatic patients (n=11) who had regular gynecologic examinations were found to have a relatively smaller tumor size, lesser extent of tumor spread, and lower recurrence rate (P=0.011, 0.283, and 0.064, respectively). The presence of endometriosis was not related to the prognosis. CONCLUSION: Considering the duration of malignant transformation and the timing of cancer diagnosis, active surveillance might be considered from the age of the mid-thirties, with at least a 1-year interval, in patients with asymptomatic endometrioma.
Cell Transformation, Neoplastic
;
Diagnosis
;
Endometriosis*
;
Female
;
Humans
;
Prognosis
;
Recurrence
;
Retrospective Studies
6.Premenopausal early-stage endometrial carcinoma patients with low CA-125 levels and low tumor grade may undergo ovary-saving surgery.
Seung Chul YOO ; Jong Hyuck YOON ; Woo Young KIM ; Suk Joon CHANG ; Hee Jae JOO ; Ki Hong CHANG ; Hee Sug RYU
Journal of Gynecologic Oncology 2009;20(3):181-186
OBJECTIVE: The purpose of this study was to determine the possible predicting factors of coexisting adnexal malignancies, and to evaluate the safety of ovary-saving surgery for early-stage endometrial carcinoma in premenopausal patients. METHODS: A retrospective review of 107 patients with endometrial carcinoma who underwent surgical treatment at our institution was conducted. All patients were younger than 50 years of age and premenopausal status. Statistical analysis was performed. RESULTS: Of the 107 patients, 78 patients had stage I to II disease and both preoperative CA-125 levels were measured and tumor grades evaluated. On multivariate analysis, preoperative CA-125 levels (p=0.018) and preoperative tumor grade (p=0.029) were independent predicting factors of adnexal diseases. The risk of coexisting ovarian malignancy was 1.8% in patients with preoperative CA-125 levels less than or equal to 34.5 U/ml and preoperative tumor grade 1 or 2. The risk increases to 20% for low CA-125 and grade 3, 13.3% for high CA-125 and grade 1 or 2, and 100% for high CA-125 and grade 3. Between patients who underwent unilateral salpingo-oophorectomy and those who underwent bilateral salpingo-oophorectomy, there was no statistically significant difference in terms of BMI, preoperative CA-125 levels, FIGO stage, histology, tumor grade, lymphadenectomy, and adjuvant treatment. CONCLUSION: Ovary-saving surgery for premenopausal, early-stage endometrial cancer patients may be considered as a treatment option in those with low preoperative CA-125 and low tumor grade.
Adnexal Diseases
;
Endometrial Neoplasms
;
Female
;
Humans
;
Lymph Node Excision
;
Multivariate Analysis
;
Retrospective Studies
7.The clinical efficacy of the low dose aspirin and corticosteroid treatment in patients with endometriosis who underwent in-vitro fertilization and embryo transfer (IVF-ET).
Young Ah KIM ; Mi Ran KIM ; Kyung Joo HWANG ; Jong Hyuck YOON ; Seong Seog SEO ; Hee Sug RYU
Korean Journal of Obstetrics and Gynecology 2002;45(3):431-437
OBJECTIVE: To investigate the efficacy of low-dose aspirin and corticosteroid in IVF-ET patients with endometriosis. MATERIALS AND METHODS: 45 infertile patients with endometriosis underwent 59 consecutive IVF-ET cycles. In the treatment group, 18 patients (23 cycles) underwent controlled ovarian hyperstimulation (COH) and received daily doses of 80 mg of aspirin and 15 mg of prednisone, starting on 3rd day of COH. In the control group, 27 patients (36 cycles) underwent COH without treatment. We analyzed the clinical characteristics, fertilization rates, good quality embryo ratio and pregnancy rates between these two groups. RESULTS: There was no difference between groups in clinical characteristics (mean age, parity, LH, FSH, estradiol, progesterone), fertilization rates, and good embryo ratio. However, implantation rates were significantly different (29.81% vs. 11.06%, p=0.019). Furthermore, hCG positive rates (60.89% vs. 41.67%), clinical pregnancy rates (56.52% vs. 33.33%), and on going pregnancy rates (>20weeks) (47.83% vs. 27.78%) were increased in the study group compared to the control group. CONCLUSIONS: Combined treatment of low dose aspirin and prednisone improved pregnancy rates and implantation rates in IVF-ET patients with endometriosis. This results confirm the hypothesis that autoantibodies subsequently react with endometrial antigen leading to implantation failure and that we need to further research to the relationship of endometriosis with the immunologic aspect of implantation.
Aspirin*
;
Autoantibodies
;
Embryo Transfer*
;
Embryonic Structures*
;
Endometriosis*
;
Estradiol
;
Female
;
Fertilization*
;
Humans
;
Parity
;
Prednisone
;
Pregnancy Rate
8.Phase IV Study on the Antihypertensive Effect and Safety of Irbesartan in Patients with Mild to Moderate Hypertension and Renal Disease.
Soo Young YOON ; Seung Hyeok HAN ; Jeong Yeob PARK ; Byoung Keuk KIM ; Young Su SONG ; Joo Seong KIM ; Jung Jung ROH ; Hyun Jin NOH ; Sug Kyun SHIN ; Kyu Hun CHOI ; Dae Suk HAN ; Ho Yung LEE
Korean Journal of Nephrology 2000;19(4):731-739
Irbesartan is a new selective angiotensin II subtype 1 receptor antagonist. We evaluated the efficacy and tolerability of irbesartan in patients with mild to moderate hypertension and renal disease. On 24 hypertensive patients, oral irbesartan 150mg a day was administered. In cases whose seated diastolic blood pressure did not decrease to 85mmHg after treatment for 4 weeks, the dose of irbesartan was increased to 300mg per day. Every 4 weeks, blood pressure, heart rates, and adverse effects were monitored. And we assessed WBC counts, hemoglobin, hematocrits, platelets, creatinine, BUN, total protein, albumin, fasting blood sugar, total cholesterol, AST, ALT, alkaline phosphatase, total bilirubin, sodium, potassium, calcium, uric acid and urine protein/creatinine ratio to evaluate the change of renal and hepatic function and other adverse effects. Seated systolic blood pressure was decreased from 157.1+/-3.1mmHg to 135.5+/-3.7mmHg, and seated diastolic blood pressure was also decreased from 99.2+/-1.7mmHg to 84.3+/-2.5mmHg. Irbesartan was effective in lowering blood pressure in 20 among 24 patients, and the effective rate of this drug was 83.3%. After treatment, a non clinically significant increase of heart rates and statistically significant decrease of total cholesterol level were noted. There was no dose-related adverse effect. We conclude that irbesartan is a safe and effective angiotensin II subtype 1 receptor antagonist for lowering blood pressure in patients with mild to moderate hypertension and renal disease.
Alkaline Phosphatase
;
Angiotensin II
;
Bilirubin
;
Blood Glucose
;
Blood Pressure
;
Calcium
;
Cholesterol
;
Creatinine
;
Fasting
;
Heart Rate
;
Hematocrit
;
Humans
;
Hypertension*
;
Potassium
;
Sodium
;
Uric Acid
9.Measuring the Burden of Disease in Korea.
Seok Jun YOON ; Sang Cheol BAE ; Sang Il LEE ; Hyejung CHANG ; Heui Sug JO ; Joo Hun SUNG ; Jae Hyun PARK ; Jin Yong LEE ; Youngsoo SHIN
Journal of Korean Medical Science 2007;22(3):518-523
This paper provides an overview of the Korean Burden of Disease (KBoD) study, which was the first such study to assess the national burden of disease using disability-adjusted life years (DALYs) in an advanced Asian country. The KBoD study generally followed the approach utilized in the original Global Burden of Disease study (GBD), with the exception of the disease classification and epidemiological data estimation methods used, and the relative weightings of disabilities. The results of the present study reveal that the burden of disease per 100,000 of the Korean population originates primarily from; cancer (1,525 Person Years, PYs), cardiovascular disease (1,492 PYs), digestive disease (1,140 PYs), diabetes mellitus (990 PYs), and certain neuro-psychiatric conditions (883 PYs). These results are largely consistent with those of developed countries, but also represent uniquely Korean characteristics.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Child
;
Child, Preschool
;
Data Collection
;
*Disease
;
*Epidemiology
;
Female
;
*Health Status
;
*Health Surveys
;
Humans
;
Infant
;
Infant, Newborn
;
Korea
;
Male
;
Middle Aged
;
Research Design
10.Asian society of gynecologic oncology workshop 2010.
Dong Hoon SUH ; Jae Weon KIM ; Mohamad Farid AZIZ ; Uma K DEVI ; Hextan Y S NGAN ; Joo Hyun NAM ; Seung Cheol KIM ; Tomoyasu KATO ; Hee Sug RYU ; Shingo FUJII ; Yoon Soon LEE ; Jong Hyeok KIM ; Tae Joong KIM ; Young Tae KIM ; Kung Liahng WANG ; Taek Sang LEE ; Kimio USHIJIMA ; Sang Goo SHIN ; Yin Nin CHIA ; Sarikapan WILAILAK ; Sang Yoon PARK ; Hidetaka KATABUCHI ; Toshiharu KAMURA ; Soon Beom KANG
Journal of Gynecologic Oncology 2010;21(3):137-150
This workshop was held on July 31-August 1, 2010 and was organized to promote the academic environment and to enhance the communication among Asian countries prior to the 2nd biennial meeting of Australian Society of Gynaecologic Oncologists (ASGO), which will be held on November 3-5, 2011. We summarized the whole contents presented at the workshop. Regarding cervical cancer screening in Asia, particularly in low resource settings, and an update on human papillomavirus (HPV) vaccination was described for prevention and radical surgery overview, fertility sparing and less radical surgery, nerve sparing radical surgery and primary chemoradiotherapy in locally advanced cervical cancer, were discussed for management. As to surgical techniques, nerve sparing radical hysterectomy, optimal staging in early ovarian cancer, laparoscopic radical hysterectomy, one-port surgery and robotic surgery were introduced. After three topics of endometrial cancer, laparoscopic surgery versus open surgery, role of lymphadenectomy and fertility sparing treatment, there was a special additional time for clinical trials in Asia. Finally, chemotherapy including neo-adjuvant chemotherapy, optimal surgical management, and the basis of targeted therapy in ovarian cancer were presented.
Asia
;
Asian Continental Ancestry Group
;
Chemoradiotherapy
;
Endometrial Neoplasms
;
Female
;
Fertility
;
Humans
;
Hysterectomy
;
Laparoscopy
;
Lymph Node Excision
;
Mass Screening
;
Ovarian Neoplasms
;
Uterine Cervical Neoplasms
;
Vaccination